Search results
File name Access Size Downloaded Type License ADAMANT a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease.pdf available 16.6 MB 7 Publisher's version 
article
Title FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease Author Novák Petr Co-authors Schmidt Reinhold Kontseková Eva Kováčech Branislav Smolek Tomáš Katina Stanislav Fialova Lubica Prcina Michal Parrák Vojtech Dal-Bianco Peter Brunner Martin Staffen Wolfgang Rainer Michael Ondrus Matej Ropele Stefan Smisek Miroslav Sivak Roman Žilka Norbert Winblad Bengt Novák Michal Source document Alzheimer's Research & Therapy. Vol. 10 (2018), art. no. 108 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2018 DOI 10.1186/s13195-018-0436-1 article